iTeos Therapeutics, Inc. 4/A SEC Filings

Filed On	Filing
03 Jun 2021	Form 4/A: McGrath Yvonne, VP, Research and Development Received 7,927 shares by exercise or conversion ($33.5K) · Sold 7,927 shares ($174K)
21 Oct 2020	Form 4/A: DiRocco Derek, Director Granted 16,608 Stock Option (Right to Buy)
21 Oct 2020	Form 4/A: Hallal David, Director Granted 16,608 Stock Option (Right to Buy)
21 Oct 2020	Form 4/A: Gadicke Ansbert, Director Granted 16,608 Stock Option (Right to Buy)
21 Oct 2020	Form 4/A: Rhoads Ann D, Director Granted 16,608 Stock Option (Right to Buy)
21 Oct 2020	Form 4/A: Davis Aaron I., Director Granted 16,608 Stock Option (Right to Buy)
21 Oct 2020	Form 4/A: Biniszkiewicz Detlev, Director Granted 16,608 Stock Option (Right to Buy)
21 Oct 2020	Form 4/A: Van Hauwermeiren Timothy, Director Granted 16,608 Stock Option (Right to Buy)

Comments